# Levothyroxine sodium

NDC: 68788-8792
Generic name: Levothyroxine sodium
Labeler / Manufacturer: Preferred Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20241217

FDA application: ANDA207588

## Active ingredients

- LEVOTHYROXINE SODIUM: 88 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-8792"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-8792
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a55e735f-a5b0-4b85-9fd7-3a4b6723a81b